... during the upcoming San Antonio Breast Cancer Symposium (SABCS) being held ... UT Health San Antonio, MD Anderson Cancer Center, commented, ...
News
- Menarini Group Presents Updated Results from Pivotal Phase 3 EMERALD Trial at the 2022 ...
- Corporate Atty Joins Jackson Walker's San Antonio Office - Law360
Jackson Walker LLP has added a senior counsel to its San Antonio office who specializes in mergers and acquisitions, private equity investments ...
- Menarini Group Presents Updated Results from Pivotal Phase 3 EMERALD Trial at the 2022 ...
Virginia Kaklamani, MD, DSc, breast medical oncologist and professor of medicine, UT Health San Antonio, MD Anderson Cancer Center, commented, “These ...
- Sana Biotechnology to lay off 15% of its employees - Puget Sound Business Journal
... Providence Raleigh/Durham Sacramento San Antonio San Francisco Seattle ... Steve Harr, CEO of Sana Biotechnology, called the cuts "painful.".
- Big Developments Set to be Unveiled at This Year's San Antonio Breast Cancer Symposium ...
The findings come ahead of this year's San Antonio Breast Cancer ... Set to present two new abstracts at the SABCS is Oncolytics Biotech Inc.